SEC Form 4 · accession 0001104659-18-071680
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Michael Gottesdiener
Officer — CEO and President · Director
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 3, 2018 | S | 563 | $30.00 | D | 571,476 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 3, 2018, Mr. Gottesdiener sold 563 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.